Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Japan flag Japan · Delayed Price · Currency is JPY
1,260.00
-5.00 (-0.40%)
Apr 28, 2026, 3:30 PM JST
23.41%
Market Cap 36.34B
Revenue (ttm) 50.77B
Net Income (ttm) 2.96B
Shares Out 28.84M
EPS (ttm) 99.47
PE Ratio 12.67
Forward PE 13.97
Dividend 40.00 (3.16%)
Ex-Dividend Date May 28, 2026
Volume 82,900
Average Volume 81,875
Open 1,261.00
Previous Close 1,265.00
Day's Range 1,246.00 - 1,263.00
52-Week Range 970.00 - 1,521.00
Beta 0.26
RSI 23.99
Earnings Date Apr 10, 2026

About Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its nam... [Read more]

Sector Healthcare
Founded 1942
Employees 1,073
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4577
Full Company Profile

Financial Performance

In fiscal year 2025, Daito Pharmaceutical's revenue was 50.64 billion, an increase of 7.99% compared to the previous year's 46.90 billion. Earnings were 1.91 billion, a decrease of -42.09%.

Financial Statements

News

There is no news available yet.